Working in biotechnology means working to improve the planet and people’s lives

Ion Arocena, CEO of AseBio, has delivered a speech at an event organised as part of the agreement that 3P Biopharmaceuticals has signed with the School of Pharmacy and Nutrition of the University of Navarra to promote training in Biotechnology

Ion Arocena, CEO of AseBio, has delivered a speech at an event organised as part of the agreement that 3P Biopharmaceuticals has signed with the School of Pharmacy and Nutrition of the University of Navarra to promote training in Biotechnology.

Working in biotechnology means working to improve the planet and people’s lives

Working in biotechnology means working to improve the planet and people’s lives, as it has an impact on 14 of the 17 sustainable development goals of the 2030 agenda“, emphasised Ion Arocena, general director of the Spanish Association of Biocompanies (AseBio), in a talk aimed at students of undergraduate and postgraduate healthcare degrees at the University of Navarra. This is the first event organised within the framework of the agreement signed by 3P and the School of Pharmacy and Nutrition of the University of Navarra to promote training and research in the technology and production of new medicines, especially biotechnological ones, and which also includes scholarships and award prizes for the most outstanding students.

During the conference, The biotechnology sector, an industry of opportunities, Arocena pointed out the wide range of sectors involved in biotechnology and its great transforming capacity, both in the health sector, to which 65% of the member companies belong, as well as in the specialised services sector (30%), the agri-food sector (14%) and industrial biotechnology (10%).

Biotech salaries are three times higher than others

According to a study by AseBio, working in the biotechnology sector means being in a field that employs around 0.6% of the active people in Spain and has an economic impact of 0.7% of the national GDP. Investment in R&D in biotechnology, which has been growing steadily since 2013, is at “record highs“, says Ion Arocena, “we are a sector that is moving and channelling large investments to generate sustainable economic growth and quality employment. We have brilliant university talent with a high participation of women, 60% in 2018, and the productivity and salary per employee in the biotech sector is three times higher than in the economy as a whole.

In terms of job opportunities, Arocena highlighted the need for specialists, both in research centres and universities and in biotech companies, in positions such as business development, marketing and sales, policy and public affairs or regulatory (work in the political and regulatory context of the activity), R&D management or scientific communication, quality and operations, or new technologies and digitalisation, a transversal discipline that focuses mainly on optimising and automating processes.

He also mentioned other types of business entities, such as industrial property agencies, where the sector offers opportunities as a patent technician; as well as consultancies and scientific advisory or venture capital companies, for advice or evaluation of biotech business projects; also pointing to the need for specialists in the field of international diplomacy and organisations.

Establishing this first channel between academia and business, which is what 3P and the University have been able to do now, is fundamental to allow students to make the leap into this biotechnological world, which is still quite unknown to them,” concluded the lecturer.

Agreement between 3P and the University of Navarra

In her speech to present the agreement between 3P and the University of Navarra, Elena Erroba, Director of Business Development at 3P Biopharmaceuticals, explained that 3P will award two €500 prizes during the next academic year 2021-2022 for the best final degree project (TFG) on Biotechnology subjects in the Pharmacy Degree and for the best final master’s project (TFM) in the Master’s Degree in Galenic Design and Industrial Manufacturing (MDGFI) in the School of Pharmacy. In addition, students of this master’s degree will be eligible for a grant of €2,000 accompanied by the possibility of a one-year paid internship at 3P.

On the other hand, and in her commitment to the research development in the field of biotechnology, Elena Erroba added that 3P is committed to providing specific equipment to the university for MDGFI students and “will continue to organise informative talks and seminars on biotechnology such as the one given today by Ion Arocena, director general of AseBio“, she stated.

Related Content

3P Biopharmaceuticals reinforces its commitment to female talent with its participation in the programme ‘Lidera en femenino-STEM’

The Head of Quality Assurance & Qualified Person at 3P Biopharmaceuticals, Susana Santesteban, has attended ‘Lidera en femenino-STEM’, a course that aims to help promote the career advancement of STEM women.
Read more

3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.
Read more

La Universidad y la empresa 3P Biopharmaceuticals potenciarán la investigación y la gestión de talento en tecnología y producción de nuevos medicamentos

Han firmado un convenio para favorecer la transformación digital y la formación de profesionales enfocados a la industria farmacéutica
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.